Consequently, HSF‐1 has garnered significant attention as a promising therapeutic target for various cancer types,66, 68, 69, 70 with HSF‐1 inhibitors holding promise as potential antitumor agents, increasing the efficacy of HSP90 inhibitors (Figure 1). This evidence concerns the gene HSP90AB1 and cancer.